APYX - Apyx Medical Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5 236.07M
Enterprise Value 3 165.21M
Trailing P/E 3.86
Forward P/E 1 -10.24
PEG Ratio (5 yr expected) 1 -0.70
Price/Sales (ttm) 12.35
Price/Book (mrq) 2.81
Enterprise Value/Revenue 3 8.64
Enterprise Value/EBITDA 6 -11.26

Trading Information

Stock Price History

Beta (3Y Monthly) 0.02
52-Week Change 3 ∞%
S&P500 52-Week Change 3 7.27%
52 Week High 3 8.89
52 Week Low 3 3.55
50-Day Moving Average 3 6.44
200-Day Moving Average 3 6.60

Share Statistics

Avg Vol (3 month) 3 226.78k
Avg Vol (10 day) 3 108.32k
Shares Outstanding 5 33.92M
Float 25M
% Held by Insiders 1 12.77%
% Held by Institutions 1 42.49%
Shares Short (Jun 28, 2019) 4 686.66k
Short Ratio (Jun 28, 2019) 4 2.48
Short % of Float (Jun 28, 2019) 4 2.10%
Short % of Shares Outstanding (Jun 28, 2019) 4 2.02%
Shares Short (prior month May 31, 2019) 4 684.86k

Dividends & Splits

Forward Annual Dividend Rate 4 N/A
Forward Annual Dividend Yield 4 N/A
Trailing Annual Dividend Rate 3 N/A
Trailing Annual Dividend Yield 3 N/A
5 Year Average Dividend Yield 4 N/A
Payout Ratio 4 0.00%
Dividend Date 3 N/A
Ex-Dividend Date 4 N/A
Last Split Factor (new per old) 2 N/A
Last Split Date 3 N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq) Mar 31, 2019

Profitability

Profit Margin 315.32%
Operating Margin (ttm) -80.27%

Management Effectiveness

Return on Assets (ttm) -15.74%
Return on Equity (ttm) -21.58%

Income Statement

Revenue (ttm) 19.11M
Revenue Per Share (ttm) 0.57
Quarterly Revenue Growth (yoy) 71.40%
Gross Profit (ttm) 10.79M
EBITDA -14.68M
Net Income Avi to Common (ttm) -11.38M
Diluted EPS (ttm) 1.80
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 73.3M
Total Cash Per Share (mrq) 2.15
Total Debt (mrq) 215k
Total Debt/Equity (mrq) 0.26
Current Ratio (mrq) 11.40
Book Value Per Share (mrq) 2.48

Cash Flow Statement

Operating Cash Flow (ttm) -24.54M
Levered Free Cash Flow (ttm) -4.5M